Cite
The Restrictive Red Blood Cell Transfusion Strategy for Critically Injured Patients (RESTRIC) trial: a cluster-randomized, crossover, non-inferiority multicenter trial of restrictive transfusion in trauma.
MLA
Hayakawa, Mineji, et al. “The Restrictive Red Blood Cell Transfusion Strategy for Critically Injured Patients (RESTRIC) Trial: A Cluster-Randomized, Crossover, Non-Inferiority Multicenter Trial of Restrictive Transfusion in Trauma.” Journal of Intensive Care, vol. 11, no. 1, July 2023, pp. 1–14. EBSCOhost, https://doi.org/10.1186/s40560-023-00682-3.
APA
Hayakawa, M., Tagami, T., Kudo, D., Ono, K., Aoki, M., Endo, A., Yumoto, T., Matsumura, Y., Irino, S., Sekine, K., Ushio, N., Ogura, T., Nachi, S., Irie, Y., Hayakawa, K., Ito, Y., Okishio, Y., Muronoi, T., Kosaki, Y., & Ito, K. (2023). The Restrictive Red Blood Cell Transfusion Strategy for Critically Injured Patients (RESTRIC) trial: a cluster-randomized, crossover, non-inferiority multicenter trial of restrictive transfusion in trauma. Journal of Intensive Care, 11(1), 1–14. https://doi.org/10.1186/s40560-023-00682-3
Chicago
Hayakawa, Mineji, Takashi Tagami, Daisuke Kudo, Kota Ono, Makoto Aoki, Akira Endo, Tetsuya Yumoto, et al. 2023. “The Restrictive Red Blood Cell Transfusion Strategy for Critically Injured Patients (RESTRIC) Trial: A Cluster-Randomized, Crossover, Non-Inferiority Multicenter Trial of Restrictive Transfusion in Trauma.” Journal of Intensive Care 11 (1): 1–14. doi:10.1186/s40560-023-00682-3.